(844) 274-8497



Cancer Pathways 2020: New Challenges & Latest Advances in Neuro-Oncology


Thank you for your interest in the Dignity Health Cancer Institute of Greater Sacramento's Pathways in Cancer CME Symposium.

Brain and other nervous system cancer is the 10th leading cause of death for men and women. Keeping up to date with progress in neuro-oncology is challenging but essential. This special half-day CME opportunity will feature recognized faculty and timely updates as they discuss the latest advances in neuro-oncology. 
  
2020 Event Details
 
Registration is now open, register below. 

 

February 1, 2020

8:00 a.m. to 1:30 p.m.

Hyatt Regency Sacramento
1209 L. Street 
Sacramento, CA 95814  

7:30 a.m. Registration, breakfast, and networking
8:00 a.m. Welcome
1:30 p.m. Closing Remarks/Adjourn


Our featured presentations will include:

Updates on Treatment for Adult Malignant Brain Tumors

Nancy Ann Oberheim Bush, MD, PhD

Advanced Radiation Treatments for Brain Tumors and Functional Disorders
Ellen Wiegner, MD

Brain Tumor Classification, Management, and New Advancements in Tumor Surgery
Yi-Ren Chen, MD

Speed Dating with NeuroOnc Imaging - A Pictorial Interactive Quick Review
Anne Marie McLellan, DO

Patient Perspective 
Iliana Flores 

Pain v. Suffering
Lisa Seo, MD


At the conclusion of this program participants should be able to implement the following changes in their professional practice:

  • Assess new glioma treatment options for patients and refer accordingly
  • Recognize the changing landscape, indicators, and technology in radiation treatments for referral of patients
  • Describe the current techniques and new treatment options available to brain tumor patients

  • Make early referral to a dietitian a goal for patients diagnosed with cancer whether they seem malnourished or not
  • Improve medical management of neurological cancers efficiently through utilization of current neuro-diagnostic imaging techniques
  • Connect to patients utilizing the universal experience principles 

  • Evaluate source of pain in patient and accurately refer patients to palliative support

Disclosures:

As a provider accredited by the California Medical Association, we must ensure balance, independence, objectivity and scientific rigor in all of our sponsored educational activities. We at Dignity Health Sacramento Office of Continuing Medical Education adhere to the ACCME Standards for Commercial Support.

  • Dr. Chen, Susan Liebert, Dr. McLellan, Dr. Oberheim Bush, Dr. Seo, Dr. Sahrakar, Dr. Wiegner, Dignity Health Sacramento CME committee members, and all other planners involved and able to influence the content of this presentation have reported no relevant financial relationships/interest with any commercial entities that may have ties to this presentation.

 


Conference Chairperson: 

Kamran Sahrakar, MD

Chief, Division of Neurosurgery, Mercy Medical Group

Dignity Health Neurological Institute of Northern CA

 

Faculty:

Nancy Ann Oberheim Bush, MD, PhD

Assistant Professor of Clinical Neurology and Neurological Surgery

UCSF Medical Director of Clinical Services for Neuro-Oncology

Division of Neuro-Oncology, Principal Investigator, Brain Tumor Center

Ellen Wiegner, MD

Radiation Oncology 

Mercy Medical Group

Yi-Ren Chen, MD

Neurosurgery 

Mercy Medical Group

Anne Marie McLellan, DO

Pediatric Neuroradiologist

Dignity Health/ Mercy Radiology

Iliana Flores

Brain Cancer Survivor

Lisa Seo, MD

Hospice & Palliative Medicine

Mercy Medical Group


Accreditation Statement:
Dignity Health Sacramento is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

Credit Designation:
Dignity Health Sacramento designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes the use of American Joint Committee on Cancer (AJCC) or other appropriate staging in clinical practice, which includes the use of appropriate prognostic indicators and evidence-based national guidelines used in treatment planning.  

This activity is sponsored in part by promotional exhibitors